Table 2 COS, IVF outcomes and OS markers in FF.
PCOS-T (n = 50) | PCOS-C (n = 50) | Non-PCOS (n = 50) | |
|---|---|---|---|
Clinical outcomes | |||
Total dose of rFSH (IU)a,b | 1791.74 ± 400.29 | 1821.02 ± 476.91 | 2119.75 ± 648.21 |
Duration of COS (d) | 10.48 ± 1.87 | 10.56 ± 1.79 | 10.26 ± 1.69 |
E2 on trigger day (pg/mL)a,b | 3903.74 ± 2532.36 | 4011.30 ± 2887.39 | 2632.99 ± 1217.87 |
E2/No. follicles ≥ 14 mm on trigger day (pg/mL) | 268.27 ± 46.57 | 279.65 ± 52.33 | 259.87 ± 45.38 |
E2/No. MII (pg/mL) | 321.56 ± 51.18 | 335.47 ± 61.62 | 317.69 ± 59.36 |
No. severe OHSS | 0 | 0 | 0 |
Embryological and pregnancy outcomes | |||
No. oocytes retrieveda,b | 15.52 ± 7.96 | 14.64 ± 6.49 | 11.72 ± 4.99 |
No. MII | 12.30 ± 6.80 | 10.02 ± 6.48 | 9.94 ± 5.30 |
No. fertilized oocytes (2PN)c | 8.80 ± 4.84 | 6.46 ± 4.61 | 7.34 ± 3.91 |
No. cleaved embryosc | 6.30 ± 4.51 | 4.32 ± 3.08 | 5.02 ± 3.62 |
No. higher-quality embryos | 3.32 ± 3.05 | 2.46 ± 2.25 | 3.00 ± 2.96 |
No. embryos transferred | 1.74 ± 0.44 | 1.78 ± 0.42 | 1.78 ± 0.42 |
Implantation rate (%) | 36.78% (32/87) | 29.21% (26/89) | 33.71% (30/89) |
Clinical pregnancy rate/ET (%) | 54.00% (27/50) | 42.00% (21/50) | 50.00% (25/50) |
Early miscarriage rate (%) | 7.41% (2/27) | 9.52% (2/21) | 4.00% (1/25) |
Multiple pregnancy rate (%) | 18.50% (5/27) | 23.80% (5/21) | 20.00% (5/25) |
FF oxidative status | |||
FF MDA (µmol/L) | 2.50 ± 1.25 | 2.51 ± 0.82 | 2.19 ± 0.70 |
FF SOD (U/mg prot) | 13.81 ± 1.50 | 13.81 ± 1.53 | 13.90 ± 2.11 |
FF TAC (mmol Trolox Eq/L) | 0.68 ± 0.09 | 0.68 ± 0.08 | 0.64 ± 0.10 |
FF TOS (µmol H2O2 Eq/L)b,c | 8.16 ± 1.88 | 10.48 ± 2.68 | 8.38 ± 2.35 |
FF OSIb,c | 12.34 ± 3.90 | 15.59 ± 5.32 | 13.10 ± 4.78 |
